Sanofi-Aventis Australia
Administration route: 
Intramuscular injection, Subcutaneous injection
Vaccine group: 
Monovalent vaccines

Registered for use in infants and children aged 2 months to 5 years.

Monovalent Haemophilus influenzae type b (Hib) vaccine

Lyophilised powder in a monodose vial with a pre-filled diluent syringe.

Each 0.5 mL reconstituted dose contains:

  • 10 µg Hib capsular polysaccharide (polyribosyl-ribitol-phosphate) conjugated to 18–30 µg tetanus protein (PRP-T)

For detailed advice on vaccine dosage, administration, contraindications and precautions, please visit the relevant disease chapter.

Page history

Last updated: 
4 June 2018
Last reviewed: 
4 June 2018


polyribosylribitol phosphate